Neurobiology of Disease Webinar and Live Chat | July 12, 2018
If you receive an error message after logging in, please refresh your browser and try to log in again a few times to override the error.
Advances in gene therapy have propelled the field into the clinical realm, and new medical treatment options are beginning to offer help in neurological diseases long thought to be incurable.
In this webinar on July 12, select faculty from the 2017 Neurobiology of Disease Workshop will continue the discussion on:
Gene targeted therapies for spinal muscular atrophy.
Gene addition in hematopoietic stem-cells for leukodystrophies.
Adeno-associated virus gene delivery for neurological disease.
After the scientific presentations, join the speakers @csumner1 @miguel.esteves @breakefield in the replies below for a live chat. Feel free to leave your questions in the Neuronline Community in advance of the live chat. *
Watch the Webinar: July 12, 1:00 p.m. EDT
Join the Live Chat: July 12, 1:45 p.m. EDT
Can’t attend live? Register to watch on-demand.
*Current and inactive SfN members log in using SfN.org information. non-SfN members create a new account.
In the live chat:
Charlotte Sumner, PhD
Charlotte J. Sumner is a professor of neurology and neuroscience at Johns Hopkins University School of Medicine.
Miguel Sena Esteves, PhD
Miguel Sena Esteves is an associate professor in the department of neurology at the University of Massachusetts Medical School.
Xandra O. Breakefield, PhD
Xandra O. Breakefield is a professor in the department of neurology at Harvard Medical School and a geneticist in neurology and radiology at Massachusetts General Hospital.
Link back to webinar